Unión Europea - español - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - istradefylline - mal de parkinson - medicamentos contra el parkinson - istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with parkinson’s disease (pd) experiencing “off” time.